These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 18207122)

  • 1. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis.
    Durand ML; Dohlman CH
    Cornea; 2009 Sep; 28(8):896-901. PubMed ID: 19654525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S; Kim B; Dohlman CH; Chodosh J
    Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
    Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
    Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Russian Keratoprosthesis in Stevens-Johnson Syndrome.
    Ma X; Xiang R; Meng X; Qin L; Wu Y; Tain L; Jiang Y; Huang Y; Wang L
    Cornea; 2017 Mar; 36(3):304-309. PubMed ID: 27941382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratoprosthesis: current techniques.
    Aquavella JV; Qian Y; McCormick GJ; Palakuru JR
    Cornea; 2006 Jul; 25(6):656-62. PubMed ID: 17077656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft.
    Hou JH; de la Cruz J; Djalilian AR
    Cornea; 2012 Dec; 31(12):1432-5. PubMed ID: 22236785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
    Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
    Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
    Alexander JK; Basak SK; Padilla MD; Yu F; Aldave AJ
    Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.